Stability of End Product Sample Clauses

Stability of End Product. Gels to be scanned for the quantitative determination of the bands must be scanned as soon as possible. Gels to be visually inspected for qualitative evaluation only may be kept an indefinite period of time after being processed. Calibration: A calibration curve is not necessary because relative concentration of the bands is the only parameter determined. Quality Control: Lipotrol (Cat. No. 5069) can be used to verify all phases of the procedure and should be used on each gel run. The control should be used as a marker for location of the lipid bands and may also be quantitated to verify the accuracy of quantitations. Refer to the package insert provided with each control for assay values. Additional QC controls may be required for federal, state or local regulations.
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Stability of End Product. The completed dried SPIFE SPE Hi Res-20 Gel is stable for an indefinite period of time. Quality Control: The Hi Res Protein Marker (Cat. No. 5141) may be used to verify appropriate protein band separation and stain sensitivity. Refer to the package insert for more information. RESULTS
Sample 1Sample 2
Stability of End Product. The color reaction is not permanent. Fading may occur after approximately 2 minutes. QUALITY CONTROL ColoCheck Monitors are provided on each CoIoScreen Slide and each tape segment. This specially treated area provides assurance that the guaiac-impregnated paper and the ColoScreen Developer are reacting according to product specifications. Positive ColoCheck Monitor is an impregnated substance in a base carrier and will turn blue within 30 seconds after application of ColoScreen Developer if the test system is reacting according to product specifications. Negative ColoCheck Monitor consists of guaiac impregnated paper and will not turn blue upon addition of ColoScreen Developer. INTERPRETATION OF RESULTS Any trace of blue color within the specimen application area is a positive for occult blood, if ColoCheck Monitors react properly. Remember always to develop the test, interpret, and record results before developing the ColoCheck Monitors. Interpretation of the test should not be done by one who is color blind. LIMITATIONS Results obtained with ColoScreen cannot be considered conclusive evidence of the presence or absence of gastrointestinal bleeding or pathology. False negative results may be obtained, since most bleeding occurs intermittently. ColoScreen tests are designed as a preliminary screen and are not intended to replace other diagnostic procedures such as proctosigmoidoscopy, barium enema or X-ray studies. ColoScreen will detect only hemoglobin released upon hemolysis of the red cell. Should whole blood be applied to the test paper, it is necessary to hemolyze the red cells by the addition of a drop of water before adding the developer. Refer to “Interfering Substances” for a further list of limiting substances. EXPECTED RESULTS The guaiac paper tests detect occult blood but they are not diagnostic for disease. Positive occult blood tests may be obtained for reasons which range from red meat in the diet, diverticulitis, hemorrhoids, colitis to colorectal cancer. Patients who have a positive test should verify that they have followed a proper diet prior to specimen collection, and should immediately consult a physician who can perform definitive tests to determine the cause of bleeding. Patients experiencing symptoms such as persistent diarrhea constipation, abdominal pain, visible bleeding, etc., should consult a physician. ColoScreen will detect 10 mg of hemoglobin per gram of homogenized fecal material.12 Guaiac impregnated paper has been extens...
Sample 1
Stability of End Product. Plates to be scanned in the densitometer for determination of the relative percentages of the bands must be scanned as soon as possible. Plates to be visually inspected for qualitative evaluation only may be kept an indefinite period of time after being processed with glycerine and as outlined above. Calibration: A calibration curve is not necessary because relative concentration of the bands is the only parameter determined.
Sample 1
Stability of End Product. The unpreserved plates are stable for three months if kept tightly closed. Dried plates are stable indefinitely.
Sample 1
Stability of End Product. Gels to be scanned for the quantitative determination of the bands must be scanned as soon as possible. Gels to be visually inspected for qualitative evaluation only may be kept an indefinite period of time after being processed. Calibration: A calibration curve is not necessary because relative concentration of the bands is the only parameter determined. Quality Control: Lipotrol (Cat. No. 5069) can be used to verify all phases of the procedure and should be used on each gel run. The control should be used as a marker for location of the lipid bands and may also be quantitated to verify the accuracy of quantitations. Refer to the package insert provided with each control for assay values. Additional QC controls may be required for federal, state or local regulations. REFERENCE VALUES Reference range studies were established using 37 male and female adults with a total cholesterol of ≤ 200 mg/dL. Lipoprotein Fraction % of Total Lipoprotein Alpha 12.6 - 46.6 Pre-Beta 0 - 57.1 Beta 21.7 - 67.7 Chylomicrons < 1.0 Any quantitation of Lp(a) must be added to pre-beta for an accurate total pre-beta. These values are intended as guidelines. Each laboratory should establish its own normal range study because of population differences in various regions.
Sample 1
Stability of End Product. For best results, scan the SPIFE Vis Cholesterol Gel within 5 minutes. Calibration: A calibration curve is not necessary as relative density of the fractions is the only parameter determined. Quality Control: Quantitation of HDL Cholesterol values should be monitored using the Cholesterol Profile Control (Cat. No. 3218). This control verifies all phases of the procedure and should be used on each gel run. Refer to the package insert provided with the control for detailed information and assay values.
Sample 1
AutoNDA by SimpleDocs

Related to Stability of End Product

  • Product ACCEPTANCE Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User(s) shall have thirty (30) days from the date of delivery to accept hardware products and sixty (60) days from the date of delivery to accept all other Product. Where the Contractor is responsible for installation, acceptance shall be from completion of installation. Failure to provide notice of acceptance or rejection or a deficiency statement to the Contractor by the end of the period provided for under this clause constitutes acceptance by the Authorized User(s) as of the expiration of that period. The License Term shall be extended by the time periods allowed for trial use, testing and acceptance unless the Commissioner or Authorized User agrees to accept the Product at completion of trial use. Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User shall have the option to run testing on the Product prior to acceptance, such tests and data sets to be specified by User. Where using its own data or tests, Authorized User must have the tests or representative set of data available upon delivery. This demonstration will take the form of a documented installation test, capable of observation by the Authorized User, and shall be made part of the Contractor’s standard documentation. The test data shall remain accessible to the Authorized User after completion of the test. In the event that the documented installation test cannot be completed successfully within the specified acceptance period, and the Contractor or Product is responsible for the delay, Authorized User shall have the option to cancel the order in whole or in part, or to extend the testing period for an additional thirty (30) day increment. Authorized User shall notify Contractor of acceptance upon successful completion of the documented installation test. Such cancellation shall not give rise to any cause of action against the Authorized User for damages, loss of profits, expenses, or other remuneration of any kind. If the Authorized User elects to provide a deficiency statement specifying how the Product fails to meet the specifications within the testing period, Contractor shall have thirty (30) days to correct the deficiency, and the Authorized User shall have an additional sixty (60) days to evaluate the Product as provided herein. If the Product does not meet the specifications at the end of the extended testing period, Authorized User, upon prior written notice to Contractor, may then reject the Product and return all defective Product to Contractor, and Contractor shall refund any monies paid by the Authorized User to Contractor therefor. Costs and liabilities associated with a failure of the Product to perform in accordance with the functionality tests or product specifications during the acceptance period shall be borne fully by Contractor to the extent that said costs or liabilities shall not have been caused by negligent or willful acts or omissions of the Authorized User’s agents or employees. Said costs shall be limited to the amounts set forth in the Limitation of Liability Clause for any liability for costs incurred at the direction or recommendation of Contractor.

  • Quality of Materials and Workmanship The Contractor shall ensure that the Construction, Materials and workmanship are in accordance with the requirements specified in this Agreement, Specifications and Standards and Good Industry Practice.

  • Product Recall (a) If a recall is required by applicable Law, or if Buyer or Supplier reasonably determines that a recall is advisable because the goods may create a potential safety hazard, are not in compliance with any applicable code, standard or legal requirement, or contain a defect or non-conformance with the requirements of this Order occurring or likely to occur in multiple goods, which such defects or non-conformances are substantially similar or have substantially similar causes or effects (collectively a “Serial Defect”), the parties shall promptly communicate such facts to each other. At Buyer’s request, Supplier shall promptly develop a corrective action plan satisfactory to Buyer, which shall include all actions required to recall and/or repair the goods and any actions required by applicable Law (“Corrective Action Plan”) for Buyer’s review and approval. At Buyer’s election, Xxxxx may develop the Corrective Action Plan. In no event shall Buyer and Supplier’s failure to agree on the Corrective Action Plan delay the timely notification of a potential safety hazard, non-compliance or Serial Defect to users of the goods, cause either party to be non-compliant with applicable Law or prevent Buyer from taking reasonable actions to prevent injury or damage to persons, equipment or other property. Supplier and Buyer shall cooperate with and assist each other in any corrective actions and/or filings, if applicable.

  • Test Samples The Contractor is responsible for providing Samples of sufficient size for test purposes and for coordinating such tests with the Work Progress Schedule to avoid delay.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

Time is Money Join Law Insider Premium to draft better contracts faster.